Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine F Carpentier

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Neurosurgery|April 8, 2017
Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for PrimetimeAymeric Amelot, Christophe Deroulers, Mathilde Badoual, et al.
Bulletin Du Cancer|March 23, 2013
[Management of brain metastases for lung cancer patients]Fabrice Barlesi, Natalia Khobta, Agnès Tallet, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2026
Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literatureStefania Cuzzubbo, Alberto Vogrig, Evelaine Louis, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
Future Oncology (London, England)|June 21, 2014
Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?Alba A Brandes, Warren Mason, Josef Pichler, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2008
Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responsesStephan Roux, Claire Bernat, Bassim Al-Sakere, et al.
Neuro-Oncology|April 6, 2021
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort studyDidier Maillet, Catherine Belin, Christine Moroni, et al.
Journal of Neurology|January 13, 2016
Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patientsAntoine Kourilsky, Guillaume Bertrand, Renata Ursu, et al.
Haematologica|September 22, 2011
Neurological disorders in essential thrombocythemiaSegolene Billot, Eirini G Kouroupi, Johan Le Guilloux, et al.
Vaccine|December 26, 2016
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumorsEmmanuelle Schaedler, Christelle Remy-Ziller, Julie Hortelano, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Neurosurgery|April 8, 2017
Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for PrimetimeAymeric Amelot, Christophe Deroulers, Mathilde Badoual, et al.
Bulletin Du Cancer|March 23, 2013
[Management of brain metastases for lung cancer patients]Fabrice Barlesi, Natalia Khobta, Agnès Tallet, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2026
Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literatureStefania Cuzzubbo, Alberto Vogrig, Evelaine Louis, et al.
Cancer Research|October 31, 2012
VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancerMagali Terme, Simon Pernot, Elie Marcheteau, et al.
Future Oncology (London, England)|June 21, 2014
Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?Alba A Brandes, Warren Mason, Josef Pichler, et al.
Cancer Immunology, Immunotherapy : CII|February 9, 2008
Tumor destruction using electrochemotherapy followed by CpG oligodeoxynucleotide injection induces distant tumor responsesStephan Roux, Claire Bernat, Bassim Al-Sakere, et al.
Neuro-Oncology|April 6, 2021
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort studyDidier Maillet, Catherine Belin, Christine Moroni, et al.
Journal of Neurology|January 13, 2016
Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patientsAntoine Kourilsky, Guillaume Bertrand, Renata Ursu, et al.
Haematologica|September 22, 2011
Neurological disorders in essential thrombocythemiaSegolene Billot, Eirini G Kouroupi, Johan Le Guilloux, et al.
Vaccine|December 26, 2016
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumorsEmmanuelle Schaedler, Christelle Remy-Ziller, Julie Hortelano, et al.
Pageof 8